|
|
 |
|
Viewing report
|
|
|
|
Vivus, Inc. - SWOT Analysis
MarketLine, Dec 2011, Pages: 23
Vivus, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Vivus, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Vivus is a pharmaceutical company focused on research, development and commercialization of products in the areas of sexual health, obesity and diabetes. The company markets Muse used for the treatment of erectile dysfunction. It primarily operates in the US. Vivus is headquartered in Mountain View, California and employed 43 people as of February 18, 2011. The company did not record revenues during the financial year (FY) ended December 2010, as compared to the revenues of $31.4 million in FY2009. The operating loss of the company was $65.6 million in FY2010, as compared with an operating loss of $53.4 million in FY2009. The net loss was $66.1 million in FY2010, as compared with a net loss of $54.3 million in FY2009.
Scope of the Report
- Provides all the crucial information on Vivus, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Vivus, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Vivus, Inc.
-Data is supplemented with details on Vivus, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Vivus, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
|
